Company · News
News
Releases, publications and announcements. Newest first.
- Kraken: our H&E foundation model, trained on 14.1 million labelled cellsJuly 2026Release
Kraken reads a routine biopsy at single-cell resolution across 14 tissue and cancer types, identifying more than ten cell types in a single pass in under two minutes. Announced with UCL Engineering.
- Immune profiling from H&E predicts chemo-radiotherapy outcome in rectal cancerNovember 2025Publication
Published in eBioMedicine, using clinical trial and real-world cohorts.
- AI-quantified tumour cell density enables precise chemo-radiotherapy planningOctober 2025Publication
Post-hoc study of the phase 3 ARISTOTLE trial, The Lancet Oncology.
- Pan-cancer mitotic figure detection with Segment AnythingDecember 2024Publication
Nature Communications Biology.
- New AI cancer pathology research platform launchedDecember 2024Launch
Octopath launched as a UCL research platform.
Press
Media enquiries
For interviews, images of the cell maps and the Kraken release notes, get in touch.